Product Information
TADALAFIL 5 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.1031 per EA under NDC 62332017815. Its NADAC has been published 375 times since Apr 24, 2019.
Strength
5 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332017815
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TADALAFILApproval Type
Generic (ANDA)
FDA Application
ANDA204809On Market Since
3/26/2019
Pharmacological Classes
Price Statistics
The NADAC for TADALAFIL 5 MG TABLET has been published 375 times since Apr 24, 2019, and over the history we have for it it has declined 98.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1031 per EA |
|---|---|
| All-time high | $8.0989 (Jun 12, 2019) |
| All-time low | $0.0842 (Nov 20, 2024) |
| 52-week high | $0.1231 |
| 52-week low | $0.1031 |
| Median price | $0.1516 |
| Average price | $0.3456 |
| Largest weekly change | -94.0% (Jun 19, 2019) |
| Weeks tracked | 375 |
| Tracking since | Apr 24, 2019 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TADALAFIL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TADALAFIL 5 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.1031 per EA (NDC 62332017815), effective Jun 24, 2026.
How has the price of TADALAFIL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for TADALAFIL 5 MG TABLET has declined 98.7%. It has been tracked across 375 weekly CMS publications since Apr 24, 2019.
What are the highest and lowest recorded NADAC prices for TADALAFIL 5 MG TABLET?
Since Apr 24, 2019, the NADAC for TADALAFIL 5 MG TABLET has ranged from a low of $0.0842 (Nov 20, 2024) to a high of $8.0989 (Jun 12, 2019), with a median of $0.1516 per EA.
Are there cheaper alternatives to TADALAFIL 5 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as TADALAFIL 5 MG TABLET, but none are currently priced below it.
Who manufactures TADALAFIL 5 MG TABLET?
TADALAFIL 5 MG TABLET (NDC 62332017815) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification